Equity Analysis /
United States of America

US : Sarepta Therapeutics, Inc. - SRPT | MDA Conference Highlights; LGMD Ph 1/2 Follow-Up Only New Data Presented

    Danielle Brill
    CGS-CIMB
    25 March 2022
    Published by